Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Page 1
Regression of calcinosis cutis after inkless tattoo in a patient with dermatomyositis: therapeutic potential of microneedling.
Motlaghzadeh Y, Tabatabai LS, Longo E, Sellmeyer DE. Motlaghzadeh Y, et al. Among authors: sellmeyer de. Osteoporos Int. 2022 Nov;33(11):2449-2452. doi: 10.1007/s00198-022-06501-z. Epub 2022 Jul 26. Osteoporos Int. 2022. PMID: 35881144
This condition is associated with severe pain and can affect the patient's quality of life and lead to long-term disability. Treatment is often challenging, and there is a very limited evidence base for potential treatments of calcinosis cutis associated with systemic scle …
This condition is associated with severe pain and can affect the patient's quality of life and lead to long-term disability. Treatmen …
Prebiotic to Improve Calcium Absorption in Postmenopausal Women After Gastric Bypass: A Randomized Controlled Trial.
Wu KC, Cao S, Weaver CM, King NJ, Patel S, Kingman H, Sellmeyer DE, McCauley K, Li D, Lynch SV, Kim TY, Black DM, Shafer MM, Özçam M, Lin DL, Rogers SJ, Stewart L, Carter JT, Posselt AM, Schafer AL. Wu KC, et al. Among authors: sellmeyer de. J Clin Endocrinol Metab. 2022 Mar 24;107(4):1053-1064. doi: 10.1210/clinem/dgab883. J Clin Endocrinol Metab. 2022. PMID: 34888663 Free PMC article. Clinical Trial.
CONCLUSION: No between-group differences were observed in changes in FCA or calciotropic hormones, but wide CIs suggest a variable impact of SCF that may be due to the degree of gut microbiome alteration. Daily SCF consumption was well tolerated. Larger and longer-term stu …
CONCLUSION: No between-group differences were observed in changes in FCA or calciotropic hormones, but wide CIs suggest a variable impact of …
A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer.
Tabatabai LS, Bloom J, Stewart S, Sellmeyer DE. Tabatabai LS, et al. Among authors: sellmeyer de. J Womens Health (Larchmt). 2019 Jan;28(1):87-92. doi: 10.1089/jwh.2017.6863. Epub 2018 Oct 12. J Womens Health (Larchmt). 2019. PMID: 30312118 Free PMC article. Clinical Trial.
Additional investigation into exercise regimens that can prevent both bone and muscle loss may help prevent long-term consequences of premenopausal breast cancer treatment....
Additional investigation into exercise regimens that can prevent both bone and muscle loss may help prevent long-term consequences of …
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.
Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE. Adler RA, et al. Among authors: sellmeyer de. J Bone Miner Res. 2016 Oct;31(10):1910. doi: 10.1002/jbmr.2918. Epub 2016 Jul 26. J Bone Miner Res. 2016. PMID: 27759931 Free article. No abstract available.
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.
Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE. Adler RA, et al. Among authors: sellmeyer de. J Bone Miner Res. 2016 Jan;31(1):16-35. doi: 10.1002/jbmr.2708. J Bone Miner Res. 2016. PMID: 26350171 Free PMC article. Review.
This ASBMR report provides guidance on BP therapy duration with a risk-benefit perspective. Two trials provided evidence for long-term BP use. In the Fracture Intervention Trial Long-term Extension (FLEX), postmenopausal women receiving alendronate for 10 years had …
This ASBMR report provides guidance on BP therapy duration with a risk-benefit perspective. Two trials provided evidence for long-term …
Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status.
Schafer AL, Weaver CM, Black DM, Wheeler AL, Chang H, Szefc GV, Stewart L, Rogers SJ, Carter JT, Posselt AM, Shoback DM, Sellmeyer DE. Schafer AL, et al. Among authors: sellmeyer de. J Bone Miner Res. 2015 Aug;30(8):1377-85. doi: 10.1002/jbmr.2467. Epub 2015 May 21. J Bone Miner Res. 2015. PMID: 25640580 Free PMC article. Clinical Trial.
Decline in FCA could contribute to the decline in BMD after RYGB, and strategies to avoid long-term skeletal consequences should be investigated....
Decline in FCA could contribute to the decline in BMD after RYGB, and strategies to avoid long-term skeletal consequences should be i …
Potassium citrate supplementation results in sustained improvement in calcium balance in older men and women.
Moseley KF, Weaver CM, Appel L, Sebastian A, Sellmeyer DE. Moseley KF, et al. Among authors: sellmeyer de. J Bone Miner Res. 2013 Mar;28(3):497-504. doi: 10.1002/jbmr.1764. J Bone Miner Res. 2013. PMID: 22991267 Free PMC article. Clinical Trial.
Readily available, safe, and easily administered in an oral form, potassium citrate has the potential to improve skeletal health. Longer-term trials with definitive outcomes such as bone density and fracture are needed....
Readily available, safe, and easily administered in an oral form, potassium citrate has the potential to improve skeletal health. Longer- …
Consistency of bone turnover marker and calcium responses to parathyroid hormone (1-84) therapy in postmenopausal osteoporosis.
Schafer AL, Palermo L, Bauer DC, Bilezikian JP, Sellmeyer DE, Black DM. Schafer AL, et al. Among authors: sellmeyer de. J Clin Densitom. 2011 Jan-Mar;14(1):68-73. doi: 10.1016/j.jocd.2010.09.001. Epub 2010 Nov 20. J Clin Densitom. 2011. PMID: 21095149 Clinical Trial.
Baseline and follow-up procollagen type I N propeptide (PINP), bone-specific alkaline phosphatase (BAP), C-terminal telopeptide (CTX), and serum and urinary calcium levels were analyzed post hoc from the 119 postmenopausal women with osteoporosis randomized to PTH(1-84) in the Pa …
Baseline and follow-up procollagen type I N propeptide (PINP), bone-specific alkaline phosphatase (BAP), C-terminal telopeptide (CTX), and s …
Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women.
Boonen S, Sellmeyer DE, Lippuner K, Orlov-Morozov A, Abrams K, Mesenbrink P, Eriksen EF, Miller PD. Boonen S, et al. Among authors: sellmeyer de. Kidney Int. 2008 Sep;74(5):641-8. doi: 10.1038/ki.2008.193. Epub 2008 May 28. Kidney Int. 2008. PMID: 18509324 Free article. Clinical Trial.
We found that transient changes in renal function can occur following an annual zoledronic acid infusion but, in the long term, renal function was not different from control patients....
We found that transient changes in renal function can occur following an annual zoledronic acid infusion but, in the long term, renal …
11 results